F&P's share price rises on news of court battle success
One patent dispute won – but two to go.
Fisher & Paykel Healthcare [NZX:FPH] has managed to fend off accusations of copycatting from its rival – for now.
The Auckland-based medical device maker announced this morning the District Court in Munich has overturned both preliminary injunctions previously granted to ResMed [NYSE:RMD]
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Already have an account? Login
Calida Smylie
Fri, 02 Dec 2016
Fri, 02 Dec 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
F&P's share price rises on news of court battle success
63576